The major findings of the present study can be summarized as follows: activated mTOR contributes to TFEB inactivation, therefore perturbing lysosomal homeostasis by impairing lysosomal biogenesis and clearance in TECs of DN. Here, MTOR is linked to liver dysplastic nodule.